Dexcom First To CGM Reimbursement Finish Line

Following a recent approval for their G5 continuous glucose monitor for use in children and adults without a finger stick, Dexcom has scored big with a new US Centers for Medicaid and Medicare Services policy that would make their CGM the first of its kind eligible for reimbursement from the agency.

More from Policy & Regulation

More from Medtech Insight